AMAG PHARMACEUTICALS INC's ticker is and the CUSIP is 00163UAA4. A total of 31 filers reported holding AMAG PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $1,265,000 | -2.2% | 1,285,000 | -0.4% | 0.18% | +2.8% |
| Q3 2018 | $1,294,000 | -5.7% | 1,290,000 | -5.5% | 0.18% | -15.6% |
| Q2 2018 | $1,372,000 | -99.9% | 1,365,000 | -0.7% | 0.21% | -9.8% |
| Q1 2018 | $1,474,811,000 | +6.1% | 1,375,000 | -1.1% | 0.24% | +4.9% |
| Q4 2017 | $1,390,542,000 | -7.8% | 1,390,000 | -2.5% | 0.22% | -14.5% |
| Q3 2017 | $1,508,961,000 | +0.9% | 1,425,000 | -0.3% | 0.26% | -7.1% |
| Q2 2017 | $1,495,566,000 | -3.9% | 1,430,000 | 0.0% | 0.28% | -6.6% |
| Q1 2017 | $1,556,598,000 | -25.9% | 1,430,000 | -3.4% | 0.30% | -30.4% |
| Q4 2016 | $2,099,558,000 | +23.3% | 1,480,000 | -2.0% | 0.43% | +21.6% |
| Q3 2016 | $1,702,676,000 | +1.0% | 1,510,000 | -1.0% | 0.36% | -7.8% |
| Q2 2016 | $1,686,391,000 | -10.0% | 1,525,000 | -0.3% | 0.39% | -14.2% |
| Q1 2016 | $1,873,454,000 | +96469.8% | 1,530,000 | -0.6% | 0.45% | -10.7% |
| Q4 2015 | $1,940,000 | -73.6% | 1,540,000 | -51.6% | 0.50% | -77.3% |
| Q3 2015 | $7,340,000 | – | 3,180,000 | – | 2.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| STEELHEAD PARTNERS LLC | 22,000,000 | $24,050,000 | 2.14% |
| LINDEN ADVISORS LP | 35,213,000 | $38,458,000 | 1.43% |
| Bruce & Co., Inc. | 5,500,000 | $5,775,000 | 1.38% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 11,003,000 | $12,059,000 | 1.23% |
| MACKAY SHIELDS LLC | 16,877,000 | $18,442,000 | 0.84% |
| ANGELO GORDON & CO., L.P. | 11,000,000 | $11,983,000 | 0.73% |
| IRON Financial LLC | 535,000 | $585,000 | 0.42% |
| WOLVERINE ASSET MANAGEMENT LLC | 18,400,000 | $20,111,000 | 0.31% |
| Sonora Investment Management, LLC | 1,430,000 | $1,556,598,000 | 0.30% |
| SSI INVESTMENT MANAGEMENT LLC | 2,830,000 | $3,084,000 | 0.28% |